CClinicalTrials.gg
CompletedNCT02443025TATUUpdated Oct 14, 2020

Teens Against Tobacco Use: A Model for Universal Tobacco Prevention and Youth Advocacy

An interventional study of Teens Against Tobacco Use in Tobacco Smoking Behavior, sponsored by The University of Texas Health Science Center, Houston. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2020-10-14.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
2,414
Allocation
Randomized
Sex
All
01

Study summary

This study evaluates the efficacy of Teens Against Tobacco Use anti-tobacco presentations on tobacco use susceptibility in 4th-8th grade. Classrooms are randomly assigned to either receive a series of two presentations or wait listed to receive them later in the school year.

Read the detailed description

The investigators will collaborate with Austin High School, Wiggs Middle School, and Guillen Middle School of the El Paso Independent School District to implement smoke free youth coalitions as an after school activity. The coalitions will follow the Teens Against Tobacco Use (TATU) model developed by the American Lung Association, the American Cancer Society, and the American Heart Association. Participating youth will be trained to develop and deliver anti-tobacco presentations to younger students. Each school will have a separate youth coalition operating under the guidance of an adult coordinator. High school youth will present to middle school classes, whereas middle school youth will present to 4th and 5th graders.

To evaluate the efficacy of the smoke-free presentations, the investigators will first match pairs of classrooms willing to have a presentation and then randomly assign one classroom in each pair to either receive the presentation first (intervention condition) or later in the school year (control condition). Following a presentation to a classroom in the intervention condition, investigators will administer a brief survey about tobacco to students in both the intervention class and its matched control class, who have not yet received a presentation. Analyses will compare intervention and control classrooms on smoking susceptibility, perceptions of harm from tobacco use, tobacco industry perceptions, and social norms on tobacco use.

02

Conditions studied

  • Tobacco Smoking Behavior
03

In context

Lead sponsor

The University of Texas Health Science Center, Houston is the lead sponsor of 880 studies on the registry; 209 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 140 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 4th to 8th grade student
  • Classroom must be willing to be randomly assigned to either receive presentations earlier in the school year or late in the school year

Exclusion criteria

Exclusion Criteria:

  • Classes in participating schools that are not in the 4th to 8th grade
  • Students not able to read English or Spanish
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,414 participants (actual)

Study arms

  • Experimental
    Intervention

    Classes receive anti-tobacco presentations from Teens Against Tobacco Use members

    Behavioral: Teens Against Tobacco Use

  • No intervention
    Wait list control

    Classes continue as usual without receiving anti-tobacco presentations from Teens Against Tobacco Use members until the end of the year, when data collection is complete.

Interventions

  • BehavioralTeens Against Tobacco Use

    Teens Against Tobacco Use teen teachers develop and then deliver anti-tobacco presentations to the target population of younger students.

06

What researchers measure

Primary outcomes

  1. Standardized Tobacco Susceptibility as assessed by 12 likert scale items drawn primarily from the global youth tobacco survey

    Tobacco susceptibility captures the likelihood of using tobacco in the future. It is a continuous variable that will be standardized, so outcomes will represent standard deviation unit differences in tobacco susceptibility.

    Time frame: within 24 hours of receiving presentation

07

Study locations

1 site
  • The University of Texas Health Science Center at Houston, School of Public Health, El Paso Regional Campus
    El Paso, Texas 79902, United States
08

References and documents

Publications

  • Brown LD, Bandiera FC, Harrell MB. Cluster Randomized Trial of Teens Against Tobacco Use: Youth Empowerment for Tobacco Control in El Paso, Texas. Am J Prev Med. 2019 Nov;57(5):592-600. doi: 10.1016/j.amepre.2019.06.013. Epub 2019 Sep 26. PubMed 31564599 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 14, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02443025
Lead sponsor
The University of Texas Health Science Center, Houston
Collaborators
Paso del Norte Health Foundation
Responsible party
Louis D. Brown (Assistant Professor, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
May 13, 2015
Start date
Nov 2014
Primary completion
Jun 2015
Completion
Jun 2015
Last update
Oct 14, 2020

Study contacts

Louis D Brown, Ph.D.
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion